晚期肺腺癌-话题@MedSci

#晚期肺腺癌#

12篇内容 | 699人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2198262, encodeId=5dc8219826297, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a> <a href='/topic/show?id=7ed165e3b6' target=_blank style='color:#2F92EE;'>#EGFR-TKIs#</a> <a href='/topic/show?id=95296e12244' target=_blank style='color:#2F92EE;'>#烟酰胺#</a>, objectTitle=CLIN CANCER RES | 烟酰胺联合EGFR-TKIs治疗EGFR突变晚期肺腺癌, objectType=article, longId=821388, objectId=39af821388e2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240412/1712926536653_6145188.jpg, objectUrl=/article/show_article.do?id=39af821388e2, replyNumber=0, likeNumber=6, createdTime=2024-04-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=39af821388e2, moduleTitle=CLIN CANCER RES | 烟酰胺联合EGFR-TKIs治疗EGFR突变晚期肺腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39af821388e2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1943245, encodeId=08421943245fd, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=Clin Oncol：晚期肺腺癌二线免疫治疗进展后Nintedanib +多西他赛三线治疗的疗效, objectType=article, longId=301250, objectId=210e30125037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=210e30125037, replyNumber=0, likeNumber=39, createdTime=2022-12-25, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=210e30125037, moduleTitle=Clin Oncol：晚期肺腺癌二线免疫治疗进展后Nintedanib +多西他赛三线治疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=210e30125037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943242, encodeId=a4eb1943242a9, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=JAMA Oncol：EGFR-TKIs治疗联合二甲双胍可明显改善晚期肺腺癌患者的PFS, objectType=article, longId=183104, objectId=0beb18310413, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0beb18310413, replyNumber=0, likeNumber=39, createdTime=2020-07-10, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0beb18310413, moduleTitle=JAMA Oncol：EGFR-TKIs治疗联合二甲双胍可明显改善晚期肺腺癌患者的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0beb18310413)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943244, encodeId=590f194324407, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=J Clin Oncol：ganetespib联合多西他赛治疗晚期肺腺癌, objectType=article, longId=184803, objectId=12f4184803fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12f4184803fa, replyNumber=0, likeNumber=41, createdTime=2020-03-20, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12f4184803fa, moduleTitle=J Clin Oncol：ganetespib联合多西他赛治疗晚期肺腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12f4184803fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943243, encodeId=96d7194324340, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=病例：吉非替尼一线治疗晚期肺腺癌一例, objectType=article, longId=183967, objectId=1e2718396ed2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1e2718396ed2, replyNumber=0, likeNumber=45, createdTime=2020-06-28, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1e2718396ed2, moduleTitle=病例：吉非替尼一线治疗晚期肺腺癌一例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e2718396ed2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943241, encodeId=4b941943241ad, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=ALK+脑膜转移晚期肺腺癌患者诊疗带来的总结与思考, objectType=article, longId=157052, objectId=6ee215e0529f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ee215e0529f, replyNumber=0, likeNumber=47, createdTime=2019-01-07, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ee215e0529f, moduleTitle=ALK+脑膜转移晚期肺腺癌患者诊疗带来的总结与思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ee215e0529f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943239, encodeId=62e01943239e9, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=Sci Rep：吉非替尼治疗的晚期肺腺癌中自噬核心基因变异的临床意义, objectType=article, longId=124579, objectId=53f71245e9fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53f71245e9fb, replyNumber=0, likeNumber=30, createdTime=2018-05-06, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53f71245e9fb, moduleTitle=Sci Rep：吉非替尼治疗的晚期肺腺癌中自噬核心基因变异的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53f71245e9fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943240, encodeId=a08a194324044, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=Lancet Respir Med：检测血浆循环肿瘤DNA的EGFR突变作为晚期肺腺癌一线吉非替尼治疗的选择标准（BENEFIT）, objectType=article, longId=144460, objectId=12e614446058, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12e614446058, replyNumber=0, likeNumber=31, createdTime=2019-05-13, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12e614446058, moduleTitle=Lancet Respir Med：检测血浆循环肿瘤DNA的EGFR突变作为晚期肺腺癌一线吉非替尼治疗的选择标准（BENEFIT）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12e614446058)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943238, encodeId=a7211943238d7, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=CLIN CANCER RES：循环肿瘤DNA指导晚期肺腺癌治疗, objectType=article, longId=112559, objectId=625911255910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=625911255910, replyNumber=0, likeNumber=39, createdTime=2018-04-04, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=625911255910, moduleTitle=CLIN CANCER RES：循环肿瘤DNA指导晚期肺腺癌治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=625911255910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943237, encodeId=55e5194323e63, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=Plos One：预测培美曲塞加铂类对晚期肺腺癌患者疗效的新方法！, objectType=article, longId=101567, objectId=c6bc10156e4e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6bc10156e4e, replyNumber=0, likeNumber=33, createdTime=2017-07-10, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6bc10156e4e, moduleTitle=Plos One：预测培美曲塞加铂类对晚期肺腺癌患者疗效的新方法！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6bc10156e4e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943236, encodeId=69eb194323604, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=JCO：阿法替尼可显著改善EGFR阳性晚期肺腺癌患者症状及生活质量, objectType=article, longId=21045, objectId=fd8c21045f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd8c21045f7, replyNumber=0, likeNumber=37, createdTime=2014-04-07, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd8c21045f7, moduleTitle=JCO：阿法替尼可显著改善EGFR阳性晚期肺腺癌患者症状及生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fd8c21045f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943235, encodeId=42f61943235bd, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联, objectType=article, longId=8408, objectId=3968840823, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3968840823, replyNumber=0, likeNumber=36, createdTime=2013-01-28, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3968840823, moduleTitle=Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3968840823)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1943234, encodeId=f16619432342f, content=<a href='/topic/show?id=40875986ec9' target=_blank style='color:#2F92EE;'>#晚期肺腺癌#</a>, objectTitle=晚期肺腺癌综合治疗1例, objectType=article, longId=2839, objectId=d50c283944, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d50c283944, replyNumber=0, likeNumber=28, createdTime=2012-05-22, rootId=0, userName=zhixianchen, userId=1e72268, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d50c283944, moduleTitle=晚期肺腺癌综合治疗1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d50c283944)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

晚期肺腺癌

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#晚期肺腺癌# #EGFR-TKIs# #烟酰胺#

CLIN CANCER RES | 烟酰胺联合EGFR-TKIs治疗EGFR突变晚期肺腺癌

2024-04-13发表于上海

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

Clin Oncol：晚期肺腺癌二线免疫治疗进展后Nintedanib +多西他赛三线治疗的疗效

2022-12-25

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

JAMA Oncol：EGFR-TKIs治疗联合二甲双胍可明显改善晚期肺腺癌患者的PFS

2020-07-10

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

J Clin Oncol：ganetespib联合多西他赛治疗晚期肺腺癌

2020-03-20

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

病例：吉非替尼一线治疗晚期肺腺癌一例

2020-06-28

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

ALK+脑膜转移晚期肺腺癌患者诊疗带来的总结与思考

2019-01-07

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

Sci Rep：吉非替尼治疗的晚期肺腺癌中自噬核心基因变异的临床意义

2018-05-06

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

Lancet Respir Med：检测血浆循环肿瘤DNA的EGFR突变作为晚期肺腺癌一线吉非替尼治疗的选择标准（BENEFIT）

2019-05-13

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

CLIN CANCER RES：循环肿瘤DNA指导晚期肺腺癌治疗

2018-04-04

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

Plos One：预测培美曲塞加铂类对晚期肺腺癌患者疗效的新方法！

2017-07-10

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

JCO：阿法替尼可显著改善EGFR阳性晚期肺腺癌患者症状及生活质量

2014-04-07

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

Cancer：基因KRAS突变与晚期肺腺癌患者更短存活相关联

2013-01-28

zhixianchen (审核中...)

前往app查看评论内容

#晚期肺腺癌#

晚期肺腺癌综合治疗1例

2012-05-22

科室
- - 订阅+
  - 更多科室
工具
服务